Skip to content

Determinants values of fasting glucose and glycated hemoglobin for the dental complications occurrence in patients with type 2 diabetes mellitus

Determination of fasting glucose and glycated hemoglobin levels preditives to dental complications occurrence in patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4smr5g
Enrollment
Unknown
Registered
2012-02-13
Start date
2010-05-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The inadequate metabolic control of diabetes mellitus associated with chronic elevations of blood glucose can result in increased susceptibility to infections, among which are the oral infections. So you have to be wary of invasive procedures to prevent local infections and / or systemic. This study aims to assess whether laboratory changes in fasting plasma glucose and glycated hemoglobin (Hb1AC) were related to clinical complications resulting from invasive dental treatment and so suggest valu

Interventions

The selected patients will be referred for care at the Department of FORP DAPE-USP in which will be submitted to anamnesis and complete physical examination protocol-specific research. In intra-oral c
procedure/surgery
E06.892

Sponsors

Faculdade de Odontologia de Ribeirão Preto da Universidade de São Paulo
Lead Sponsor
Hospital das Clínicas - Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diabetes patients assisted at the Diabetes Clinic of the Division of Endocrinology, Hospital das Clinicas, Faculty of Medicine of Ribeirao Preto / USP (HC-FMRP/USP), and the DAPE Service (Demystifying Dental Care to Patients with Special Needs) School of Dentistry of Ribeirão Preto / USP (FORP-USP)will participate in this study and nondiabetic individuals assisted at the Faculty of Dentistry of Ribeirão Preto - USP (FORP / USP). Selected patients will be diagnosed with type 2 diabetes based on the recommendations of the World Health Organization, with progression of the disease at least 5 years, of both sexes, with no predilection for race, over 18 years. Patients must have indication for periodontal dental treatment and/or surgery.

Exclusion criteria

Exclusion criteria: Type 2 diabetics patients presenting microvascular and macrovascular complications (diabetic retinopathy with vision loss, diabetic neuropathy, diabetic foot + resulting in amputations, coronary heart disease, peripheral arterial disease, cerebrovascular disease, nephropathy developed with the need for dialysis, except for periodontal disease ) patients with systemic or local infectious diseases beyond the mouth, showing malignancy or any other type of disease and drugs that result in immunosuppression, smoking, individuals who have made use of systemic antibiotics in the three months preceding the study. Are also excluded patients with diabetes have changes in dosage of medication taken within 3 months prior to dental care. The clinical examination will exclude individuals presenting PSR 1 or 2, presenting less than 6 mouth dental elements, individuals with lesions in the oral mucosa, and those who disagree on signing the informed consent.

Design outcomes

Primary

MeasureTime frame
Oral complications occurrence after invasive dental proceeds (tooth extraction, and simple scaling and root planing).

Secondary

MeasureTime frame
Pain, edema, bleeding, and surgical site infection. These complications will be evaluated by clinical anamnesis: it will be performed extra and intraoral physical examination and the research for symptoms using visual analogue scale. It will be compared the outcomes between the three study groups.

Countries

Brazil

Contacts

Public ContactAna Carolina Motta

Faculdade de Odontologia de Ribeirão Preto- USP

anacfm@usp.br55-16-3602-4109

Outcome results

None listed

Source: REBEC (via WHO ICTRP)